Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Canopy Growth Corporation
Canopy Growth Corporation
Industry · 10 registered clinical trials.
Status
Trial
Phase
Started
Completed
A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on
Healthy Adults
Phase 1 / Phase 2
2022-05-16
Terminated
CBD in Postmenopausal Women With Osteopenia
Osteopenia
Phase 1
2022-05-01
Completed
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy Participants
Healthy Adults
Phase 1
2022-01-11
Completed
Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity
Delayed Onset Muscle Soreness (DOMS)
Phase 2
2021-12-13
Unknown
Canadian Registry for the Use of Spectrum Therapeutics Cannabis Products in Subjects With Chronic Pain
Chronic Pain
—
2021-01-25
Completed
The Effects of CBD Isolate on Menstrual-Related Symptoms
Menstrual Discomfort
Phase 2
2020-09-23
Completed
A Randomized Controlled Test of the Effects of CHI-554 on Fear.
Anxiety, Fear, Panic
Phase 2
2020-09-01
Terminated
CHI-907 CBD Extract and Experiences of Test Anxiety
Anxiety
Phase 2
2020-02-03
Withdrawn
CHI-902 for Treatment of Social Anxiety Disorder
Social Anxiety Disorder
Phase 2
2020-01-24
Terminated
Investigation of the Efficacy and Safety of CHI-921 in Insomnia.
Insomnia
Phase 2
2019-03-21